Idursulfase
From Infogalactic: the planetary knowledge core
Clinical data | |
---|---|
AHFS/Drugs.com | monograph |
Identifiers | |
CAS Number | 50936-59-9 |
ATC code | A16AB09 (WHO) |
DrugBank | DB01271 |
UNII | 5W8JGG2651 |
KEGG | D04499 |
ChEMBL | CHEMBL1201826 |
(what is this?) (verify) |
Idursulfase (brand name Elaprase), manufactured by Shire, is a drug used to treat Hunter syndrome (also called MPS-II).[1] It is a purified form of the lysosomal enzyme iduronate-2-sulfatase and is produced by recombinant DNA technology in a human cell line.
It is one of the most expensive drugs ever produced, costing US$567,412 per patient per year.[2][3][4]
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Health Care: The World's Most Expensive Drugs, Matthew Herper, Forbes, Feb. 22, 2010
- ↑ [1], Barbara Kollmeyer, Marketwatch, Fed. 3, 2016
External links
- idursulfase at the US National Library of Medicine Medical Subject Headings (MeSH)
<templatestyles src="Asbox/styles.css"></templatestyles>